help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qian, J.
Right arrow Articles by Clemens, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qian, J.
Right arrow Articles by Clemens, T. L.
Endocrinology Vol. 140, No. 4 1826-1833
Copyright © 1999 by The Endocrine Society


ARTICLES

Reduced Blood Pressure and Increased Sensitivity of the Vasculature to Parathyroid Hormone-Related Protein (PTHrP) in Transgenic Mice Overexpressing the PTH/PTHrP Receptor in Vascular Smooth Muscle1

Jin Qian, John N. Lorenz, Shigeto Maeda, Roy L. Sutliff, Craig Weber, Toshiyuki Nakayama, Melissa C. Colbert, Richard J. Paul, James A. Fagin and Thomas L. Clemens

Division of Endocrinology and Metabolism, Departments of Medicine (J.Q., S.M., T.N., J.A.F., T.L.C.) and Molecular and Cellular Physiology (J.N.L., R.L.S., C.W., R.J.P., J.A.F., T.L.C.), University of Cincinnati, and the Department of Pediatrics, Children’s Hospital (M.C.C.), Cincinnati, Ohio 45267

Address all correspondence and requests for reprints to: Thomas L. Clemens, Ph.D., Division of Endocrinology and Metabolism, University of Cincinnati, Room 5564, 231 Bethesda Avenue, Cincinnati, Ohio 45267-0547. E-mail: clementl{at}uc.edu

PTH-related protein (PTHrP) is produced in vascular smooth muscle, where it is postulated to exert vasorelaxant properties by activation of the PTH/PTHrP type 1 receptor. As a model for studying the actions of locally produced PTHrP in vascular smooth muscle in vivo, we developed transgenic mice that overexpress the PTH/PTHrP receptor (PTHrP-R) in smooth muscle. Oocyte injection with a SMP8-PTHrP-R fusion construct yielded six founder mice. F1 offspring were viable and demonstrated selective overexpression of the SMP8-PTHP-R messenger RNA in smooth muscle-rich tissues. Baseline blood pressure measured in conscious mice by tail sphygmomanometry was significantly lower in the receptor-overexpressing mice than that in controls (117 ± 4 vs. 133 ± 3 mm Hg; P < 0.05). In anesthetized animals, iv infusion of PTHrP-(1–34)NH2 caused a significantly greater reduction in blood pressure and total peripheral resistance in transgenic mice than in control animals. Vascular contractility was studied in paired, isometrically mounted aortas from 9-week-old transgenic and wild-type mice. The force of contraction in response to phenlyephrine was not significantly different between transgenic and wild-type mice. However, PTHrP-(1–34) NH2 relaxed aortic vessel preparations from transgenic mice to a greater extent than in controls (77.1 ± 3% vs. 38.4 ± 4%; P < 0.001). To determine the impact of overexpression of PTH/PTHrP type 1 receptor and its ligand on the development of the cardiovascular system, double transgenic mice were created by crossing SMP8-PTHrP-R transgenic mice with mice overexpressing PTHrP (SMP8-PTHrP). Double transgenic mice died around day E9 with abnormalities in the developing heart. In conclusion, overexpression of PTH/PTHrP type 1 receptor in vascular smooth muscle of transgenic mice reduces blood pressure, probably through sustained activation of the receptor by endogenous ligand. The cardiovascular defects observed in mice overexpressing both PTHrP and its receptor suggest that PTHrP may play a role in the normal development of the cardiovascular system.




This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Welsch, E. Schordan, C. Coquard, T. Massfelder, N. Fiaschi-Taesch, J.-J. Helwig, and M. Barthelmebs
Abnormal Renovascular Parathyroid Hormone-1 Receptor in Hypertension: Primary Defect or Secondary to Angiotensin II Type 1 Receptor Activation?
Endocrinology, September 1, 2006; 147(9): 4384 - 4391.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Chen, W. Stuart, B. Hu, L. Nguyen, G. Huang, T. L. Clemens, and J. S. Adams
Creation of Estrogen Resistance in Vivo by Transgenic Overexpression of the Heterogeneous Nuclear Ribonucleoprotein-Related Estrogen Response Element Binding Protein
Endocrinology, October 1, 2005; 146(10): 4266 - 4273.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Fritsch, V. Lindner, S. Welsch, T. Massfelder, M. Grima, S. Rothhut, M. Barthelmebs, and J.-J. Helwig
Intravenous Delivery of PTH/PTHrP Type 1 Receptor cDNA to Rats Decreases Heart Rate, Blood Pressure, Renal Tone, Renin Angiotensin System, and Stress-Induced Cardiovascular Responses
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2588 - 2600.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Fiaschi-Taesch, K. K. Takane, S. Masters, J. C. Lopez-Talavera, and A. F. Stewart
Parathyroid Hormone-Related Protein as a Regulator of pRb and the Cell Cycle in Arterial Smooth Muscle
Circulation, July 13, 2004; 110(2): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. T. Noonan, J. Qian, W. D. Stuart, T. L. Clemens, and J. N. Lorenz
Altered Renal Hemodynamics in Mice Overexpressing the Parathyroid Hormone (PTH)/PTH-Related Peptide Type 1 Receptor in Smooth Muscle
Endocrinology, November 1, 2003; 144(11): 4931 - 4938.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Qian, M. C. Colbert, D. Witte, C.-Y. Kuan, E. Gruenstein, H. Osinska, B. Lanske, H. M. Kronenberg, and T. L. Clemens
Midgestational Lethality in Mice Lacking the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Is Associated with Abrupt Cardiomyocyte Death
Endocrinology, March 1, 2003; 144(3): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Cebrian, A. Garcia-Ocana, K. K. Takane, D. Sipula, A. F. Stewart, and R. C. Vasavada
Overexpression of Parathyroid Hormone-Related Protein Inhibits Pancreatic {beta}-Cell Death In Vivo and In Vitro
Diabetes, October 1, 2002; 51(10): 3003 - 3013.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Eichinger, N. Fiaschi-Taesch, T. Massfelder, S. Fritsch, M. Barthelmebs, and J.-J. Helwig
Transcript Expression of the Tuberoinfundibular Peptide (TIP)39/PTH2 Receptor System and Non-PTH1 Receptor-Mediated Tonic Effects of TIP39 and Other PTH2 Receptor Ligands in Renal Vessels
Endocrinology, August 1, 2002; 143(8): 3036 - 3043.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. N. Lorenz
A practical guide to evaluating cardiovascular, renal, and pulmonary function in mice
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1565 - R1582.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Massfelder, N. Taesch, S. Fritsch, A. Eichinger, M. Barthelmebs, A. F. Stewart, and J.-J. Helwig
Type 1 Parathyroid Hormone Receptor Expression Level Modulates Renal Tone and Plasma Renin Activity in Spontaneously Hypertensive Rat
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 639 - 648.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. L. Clemens, J. Qian, and M. C. Colbert
Editorial: Prenatal Lethality in PTH Type I Receptor Null Mice--Interrogating the Usual Suspects
Endocrinology, December 1, 2001; 142(12): 5056 - 5058.
[Full Text] [PDF]


Home page
EndocrinologyHome page
D. W. Soegiarto, S. Kiachopoulos, E. Schipani, H. Juppner, R. G. Erben, and B. Lanske
Partial Rescue of PTH/PTHrP Receptor Knockout Mice by Targeted Expression of the Jansen Transgene
Endocrinology, December 1, 2001; 142(12): 5303 - 5310.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. de Miguel, N. Fiaschi-Taesch, J. C. Lopez-Talavera, K. K. Takane, T. Massfelder, J.-J. Helwig, and A. F. Stewart
The C-Terminal Region of PTHrP, in Addition to the Nuclear Localization Signal, Is Essential for the Intracrine Stimulation of Proliferation in Vascular Smooth Muscle Cells
Endocrinology, September 1, 2001; 142(9): 4096 - 4105.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Mizuno, N. Ono, and T. Ohhashi
Parathyroid hormone-related protein-(1-34) inhibits intrinsic pump activity of isolated murine lymph vessels
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H60 - H66.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. J. Wysolmerski, S. Cormier, W. M. Philbrick, P. Dann, J.-P. Zhang, J. Roume, A.-L. Delezoide, and C. Silve
Absence of Functional Type 1 Parathyroid Hormone (PTH)/PTH-Related Protein Receptors in Humans Is Associated with Abnormal Breast Development and Tooth Impaction
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1788 - 1794.
[Abstract] [Full Text]


Home page
FASEB J.Home page
T. MASSFELDER, N. TAESCH, N. ENDLICH, A. EICHINGER, B. ESCANDE, K. ENDLICH, M. BARTHELMEBS, and J.-J. HELWIG
Paradoxical actions of exogenous and endogenous parathyroid hormone-related protein on renal vascular smooth muscle cell proliferation: reversion in the SHR model of genetic hypertension
FASEB J, March 1, 2001; 15(3): 707 - 718.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. D. Stuart, S. Maeda, P. Khera, J. A. Fagin, and T. L. Clemens
Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells
Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E60 - E67.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. M. Faraci and C. D. Sigmund
Vascular Biology in Genetically Altered Mice : Smaller Vessels, Bigger Insight
Circ. Res., December 3, 1999; 85(12): 1214 - 1225.
[Full Text] [PDF]


Home page
EndocrinologyHome page
T. Massfelder and J.-J. Helwig
Editorial: Parathyroid Hormone-Related Protein in Cardiovascular Development and Blood Pressure Regulation
Endocrinology, April 1, 1999; 140(4): 1507 - 1510.
[Full Text]


Home page
EndocrinologyHome page
S. Maeda, R. L. Sutliff, J. Qian, J. N. Lorenz, J. Wang, H. Tang, T. Nakayama, C. Weber, D. Witte, A. R. Strauch, et al.
Targeted Overexpression of Parathyroid Hormone-Related Protein (PTHrP) to Vascular Smooth Muscle in Transgenic Mice Lowers Blood Pressure and Alters Vascular Contractility
Endocrinology, April 1, 1999; 140(4): 1815 - 1825.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
K.-L. Laugwitz, H.-J. Weig, A. Moretti, E. Hoffmann, P. Ueblacker, I. Pragst, K. Rosport, A. Schomig, and M. Ungerer
Gene Transfer of Heterologous G Protein-Coupled Receptors to Cardiomyocytes : Differential Effects on Contractility
Circ. Res., April 13, 2001; 88(7): 688 - 695.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society